Skip to main content

Joan Genescà Ferrer

Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.

Institutions of which they are part

Head of group
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Joan Genescà Ferrer

Institutions of which they are part

Head of group
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.

Chief Liver Unit.
Clinical director of Digestive Diseases.
Professor of Medicine of the UAB.

Projects

La inhibició de la transmissió adrenèrgica contribueix a la vasodilatació esplàcnica de la hipertensió portal

IP: Joan Genescà Ferrer
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding: 36000
Reference: POST-MIR/CAIX/02/07
Duration: 01/07/2007 - 30/06/2009

CIBER Enfermedades hepáticas y digestivas (CIBEREHD)

IP: Joan Genescà Ferrer
Collaborators: Lluís Palenzuela Díaz, Nuria Raguer Sanz
Funding agency: CIBER Enfermedades Hepáticas y Digestivas
Funding:
Reference: CB06/04/0007
Duration: 01/01/2007 - 31/12/2010

Utilidad de la PCR bacteriana en el diagnostico de la peritonitis bacteriana espontánea del cirrotico.

IP: Joan Genescà Ferrer
Collaborators: Antonio González Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 15205.61
Reference: 01/1390
Duration: 17/07/2001 - 31/12/2002

Estudio longitudinal de la expresión génica diferencial de la alteración vascular esplácnica en el modelo experimental de hipertensión portal de rata. Papel de los mecanismos de angiogénesis

IP: Joan Genescà Ferrer
Collaborators: Antonio González Fernández, Maria Nieves Martell Pérez-Alcalde
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 83490
Reference: SAF2006-03714
Duration: 01/10/2006 - 30/09/2009

Ministerio de Ciencia

Related news

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Related professionals

María Díaz Hervás

María Díaz Hervás

Predoctoral researcher
Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Maria Teresa Contijoch Mateos

Maria Teresa Contijoch Mateos

Transfusional Medicine
Read more
Lourdes Zamorano Moreno

Lourdes Zamorano Moreno

Zelador/a
General Services and Infrastructures Unit
Manager
Read more
Mónica Pamies Serrano

Mónica Pamies Serrano

Biomedical Research in Gynaecology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.